Pediatric Admissions During the COVID-19 Pandemic in a Hospital With Low Prevalence of SARS-CoV-2

Jordon C Mitzelfelt1,2, Kristin C Mara3, Jaclyn Whelan4

  • 1Department of Pediatrics, Mayo Clinic Children's, Rochester, MN, USA.

Insights

The COVID-19 pandemic altered pediatric hospital admissions, decreasing overall numbers but changing diagnosis patterns. These shifts highlight the need for flexible healthcare planning during public health crises.

Area of Science:

  • Pediatric Healthcare
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic necessitated evaluating healthcare system resilience and resource allocation during crises.
  • Understanding changes in pediatric hospital admissions is crucial for pandemic preparedness.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on pediatric hospital admission patterns.
  • To compare diagnosis trends before and during the pandemic at a children's hospital.

Main Methods:

  • Retrospective, single-center, cross-sectional study of 33,158 pediatric admissions (≤17 years) from 2017-2021.
  • Data abstracted from Vizient Clinical Data Base and internal data warehouse.
  • Poisson regression used to compare pre- and intra-pandemic admission diagnoses.

Main Results:

  • Overall hospital and PICU admissions decreased significantly (p<0.01) at the pandemic's onset.
  • Significant shifts observed in infectious and seizure-related diagnoses.
  • Increase noted in specific mental health diagnoses; viral bronchiolitis seasonality disrupted.

Conclusions:

  • The COVID-19 pandemic significantly impacted pediatric admission volume and patterns, despite low SARS-CoV-2 prevalence.
  • Observed changes likely linked to community mitigation strategies, not just direct viral impact.
  • Findings offer insights for healthcare planning during future pandemics.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.8K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434